close
Breaking news

A new line of argument has already come to dominate the public sphere: it’...read more The government has gone one step further to detect community spread of the coro...read more The government has issued an order to abolish the six allowances, including the...read more Aarogya Setu application launched by NIC is aimed to track COVID-19 affected pe...read more SEOUL| South Korea’s unemployment rate was unchanged in April as the coronavi...read more Amid the outbreak of Corona pandemic in the country, Indian government has been...read more Prime Minister Narendra Modi in his address to the nation on Tuesday indicated ...read more Corona infection in the country is taking a macabre form. So far, more than 74 ...read more Congress General Secretary Priyanka Gandhi Vadra has written a letter to UP Chi...read more On Tuesday, Prime Minister Narendra Modi announced a package of Rs 20 lakh cror...read more

Pfizer Asks For Emergency Approval of Covid Vaccine in India

Pfizer Asks for Covid Vaccine Emergency Approval

The Indian unit of drug maker Pfizer has applied to the Drug Controller General of India (DCGI) for formal approval for emergency use of the Covid-19 vaccine developed by it. Pfizer made this request after its Covid-19 vaccine was approved in the UK and Bahrain.

Official sources said that in its application filed to the drug regulator, the company has requested approval for import and distribution of the vaccine in the country. Apart from this, under the special provisions of the Drugs and Clinical Trials Rules, 2019, the population of India is also requested to be exempted from clinical trials.

The source said that Pfizer India has applied to the DGCI on December 4 for approval for the emergency use of its Covid-19 vaccine in India. The UK on Wednesday granted temporary approval for Pfizer’s Covid-19 vaccine for emergency use.

Bahrain became the second country in the world after Britain to formally approve the emergency use of the Covid-19 vaccine developed by pharmaceutical manufacturer Pfizer and its German partner Bioentech. The pharmaceutical company has already applied for such approval in the US.

Story Page